{"id":640,"date":"2013-01-31T11:27:50","date_gmt":"2013-01-31T15:27:50","guid":{"rendered":"http:\/\/blogviejo.sld.cu\/inmuno\/?p=640"},"modified":"2013-01-31T11:27:50","modified_gmt":"2013-01-31T15:27:50","slug":"clinical-development-of-monoclonal-antibody-based-drugs-in-hiv-and-hcv-diseases","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/inmuno\/2013\/01\/31\/clinical-development-of-monoclonal-antibody-based-drugs-in-hiv-and-hcv-diseases\/","title":{"rendered":"Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases"},"content":{"rendered":"<p><a title=\"PDF, 2.9 MB\" href=\"http:\/\/www.biomedcentral.com\/content\/pdf\/1741-7015-11-4.pdf\" target=\"_blank\">BMC Medicine 2013;11:4<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BMC Medicine 2013;11:4<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[6,5,20,22,23,29],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts\/640"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/comments?post=640"}],"version-history":[{"count":0,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts\/640\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/media?parent=640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/categories?post=640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/tags?post=640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}